FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

ALESSANDRO MASSIMO GIANNI

Research Profile

Anatomy

Hematopoietic Stem Cells

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Donald A Berry; Marco Bregni; Jean Caputo; R Charles Coombes; John P Crown; Elisabeth G E de Vries; William E Barlow; Russell L Basser; Jonas Bergh; ALESSANDRO MASSIMO GIANNI; Gabriel N Hortobagyi; Marcella M Johnson; Xiudong Lei; Robert C Leonard; Ulrike A Nitz; Paolo Pedrazzoli; William P Peters; Henri Roché; Sjoerd Rodenhuis; Martin S Tallman; Yutaka Tokuda; Naoto T Ueno; Axel R Zander; Taner Demirer
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
Simonetta Viviani; Francesco Zaja; Pier Luigi Zinzani; Delia Rota Scalabrini; Gianni Bonadonna; Valeria Bonfante; Ercole Brusamolino; Andrea Gallamini; ALESSANDRO MASSIMO GIANNI; Manuel Gotti; Alessandro Levis; Anna Marina Liberati; Enrico M Pogliani; Patrizia Pregno; Alessandro Pulsoni; Alessandro Rambaldi; Andrea Rossi; Giorgina Specchia; Pinuccia Valagussa; Umberto Vitolo
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Michael Mian; Luigi Marcheselli; stefano luminari; Massimo Federico; Maria Cantonetti; Andreas H Sarris; Andrea Rossi; Alessandro Rambaldi; Marina Frontani; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Mario Busetto; Emilio Berti; Giovanni Martinelli; Richard W Tsang; Andrés J M Ferreri; Graziella Pinotti; Enrico Pogliani; Emanuele Zucca; Sergio Cortelazzo
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of ALESSANDRO MASSIMO GIANNI (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Donald A Berry; Marco Bregni; Jean Caputo; R Charles Coombes; John P Crown; Elisabeth G E de Vries; William E Barlow; Russell L Basser; Jonas Bergh; ALESSANDRO MASSIMO GIANNI; Gabriel N Hortobagyi; Marcella M Johnson; Xiudong Lei; Robert C Leonard; Ulrike A Nitz; Paolo Pedrazzoli; William P Peters; Henri Roché; Sjoerd Rodenhuis; Martin S Tallman; Yutaka Tokuda; Naoto T Ueno; Axel R Zander; Taner Demirer
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3214-23.
2011: Simonetta Viviani; Francesco Zaja; Pier Luigi Zinzani; Delia Rota Scalabrini; Gianni Bonadonna; Valeria Bonfante; Ercole Brusamolino; Andrea Gallamini; ALESSANDRO MASSIMO GIANNI; Manuel Gotti; Alessandro Levis; Anna Marina Liberati; Enrico M Pogliani; Patrizia Pregno; Alessandro Pulsoni; Alessandro Rambaldi; Andrea Rossi; Giorgina Specchia; Pinuccia Valagussa; Umberto Vitolo
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
The New England journal of medicine 2011;365(3):203-12.
2011: Michael Mian; Luigi Marcheselli; stefano luminari; Massimo Federico; Maria Cantonetti; Andreas H Sarris; Andrea Rossi; Alessandro Rambaldi; Marina Frontani; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Mario Busetto; Emilio Berti; Giovanni Martinelli; Richard W Tsang; Andrés J M Ferreri; Graziella Pinotti; Enrico Pogliani; Emanuele Zucca; Sergio Cortelazzo
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).
Annals of hematology 2011;90(4):401-8.
2011: Corrado Tarella; Roberto Passera; Michele Magni; Fabio Benedetti; Andrea Rossi; Angela Gueli; Caterina Patti; Guido Parvis; Fabio Ciceri; Andrea Gallamini; Sergio Cortelazzo; Valerio Zoli; Paolo Corradini; Alessandra Carobbio; Antonino Mulé; Marco Bosa; Anna Barbui; Massimo Di Nicola; Marco Sorio; Daniele Caracciolo; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):814-24.
2011: Andrea Gallamini; Caterina Patti; Simonetta Viviani; Andrea Rossi; Francesca Fiore; Francesco Di Raimondo; Maria Cantonetti; Caterina Stelitano; Tatyana Feldman; Paolo Gavarotti; Roberto Sorasio; Antonino Mulè; Monica Leone; Alessandro Rambaldi; Alberto Biggi; Sally Barrington; Federico Fallanca; Umberto Ficola; Stéphane Chauvie; ALESSANDRO MASSIMO GIANNI
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
British journal of haematology 2011;152(5):551-60.
2010: Roberta Zappasodi; Serenella M Pupa; Gaia C Ghedini; Italia Bongarzone; Michele Magni; Antonello D Cabras; Mario P Colombo; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI; Massimo Di Nicola
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
Cancer research 2010;70(22):9062-72.
2010: Aurora Mirabile; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Antonello Domenico Cabras; Antonino Carbone
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
American journal of hematology 2010;85(10):815-7.
2010: Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Leukemia & lymphoma 2010;51(7):1251-9.
2010: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; liliana devizzi; Anna Guidetti; Paola Matteucci; ALESSANDRO MASSIMO GIANNI
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
Bone marrow transplantation 2010;45(6):1119-20.
2010: Cristiana Lavazza; Carmelo Carlo-Stella; Arianna Giacomini; Loredana Cleris; Marco Righi; Daniela Sia; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Maura Francolini; Annunziata Gloghini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
Blood 2010;115(11):2231-40.
2010: Umberto Vitolo; Giovanni Barosi; Stefano Fanti; ALESSANDRO MASSIMO GIANNI; Maurizio Martelli; Mario Petrini; Pier Luigi Zinzani; Sante Tura
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.
American journal of hematology 2010;85(2):147-55.
2010: Spinello Antinori; M Corbellino; A Necchi; Paolo Corradini; Claudio Vismara; Vittorio Montefusco; ALESSANDRO MASSIMO GIANNI
Immune reconstitution inflammatory syndrome associated with Aspergillus terreus pulmonary infection in an autologous stem cell transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society 2010;12(1):64-8.
2010: Michele Magni; Massimo Di Nicola; Adele Testi; Antonello Cabras; liliana devizzi; Anna Guidetti; Paola Matteucci; Simonetta Viviani; Valeria Bonfante; Cristiana Carniti; Irene Ricca; Antonino Carbone; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
Radioimmunotherapy and secondary leukemia: a case report.
Leukemia research 2010;34(1):e1-4.
2009: Carlo Chiesa; F Botta; Angela Coliva; Marco Maccauro; liliana devizzi; Anna Guidetti; Carmelo Carlo-Stella; Ettore Seregni; ALESSANDRO MASSIMO GIANNI; Emilio Bombardieri
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin's lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
European journal of nuclear medicine and molecular imaging 2009;36(11):1745-57.
2009: Marco Righi; Arianna Giacomini; Cristiana Lavazza; Daniela Sia; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments.
Laboratory investigation; a journal of technical methods and pathology 2009;89(9):1063-70.
2009: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; liliana devizzi; Corrado Tarella; Fabio Benedetti; Maurizio Martelli; Caterina Patti; Guido Parvis; Alessandro Rambaldi; T Barbui; ALESSANDRO MASSIMO GIANNI
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
Bone marrow transplantation 2009;43(6):509-11.
2009: Christian Gisselbrecht; Julie Vose; Auayporn Nademanee; ALESSANDRO MASSIMO GIANNI; Arnon Nagler
Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
The oncologist 2009;14 Suppl 2():41-51.
2009: Massimo Di Nicola; Roberta Zappasodi; Carmelo Carlo-Stella; Roberta Mortarini; Serenella M Pupa; Michele Magni; liliana devizzi; Paola Matteucci; Paola Baldassari; Fernando Ravagnani; Antonello Cabras; Andrea Anichini; ALESSANDRO MASSIMO GIANNI
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Blood 2009;113(1):18-27.
2008: liliana devizzi; Anna Guidetti; Corrado Tarella; Michele Magni; Paola Matteucci; Ettore Seregni; Carlo Chiesa; Emilio Bombardieri; Massimo Di Nicola; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5175-82.
2008: Roberta Zappasodi; Massimo Di Nicola; Carmelo Carlo-Stella; Roberta Mortarini; Alessandra Molla; Claudia Vegetti; Salvatore Albani; Andrea Anichini; ALESSANDRO MASSIMO GIANNI
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Haematologica 2008;93(10):1523-34.
2008: Corrado Tarella; Manuela Zanni; Michele Magni; Fabio Benedetti; Caterina Patti; Tiziano Barbui; Alessandro Pileri; Mario Boccadoro; Fabio Ciceri; Andrea Gallamini; Sergio Cortelazzo; Ignazio Majolino; Salvo Mirto; Paolo Corradini; Roberto Passera; Giovanni Pizzolo; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3166-75.
2008: marco ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna Marina Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Roberto Passera; Paolo Corradini; Corrado Tarella; Delia Rota Scalabrini
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.
Blood 2008;111(8):4004-13.
2008: Milena Sant; Claudia Allemani; Roberta De Angelis; Antonino Carbone; Silvia de Sanjosè; ALESSANDRO MASSIMO GIANNI; Pilar Giraldo; Francesca Marchesi; Rafael Marcos-Gragera; carmen martos; Marc Maynadié; Martine Raphael; Franco Berrino
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.
European journal of cancer (Oxford, England : 1990) 2008;44(4):579-87.
2008: G Ryan; G Martinelli; M Kuper-Hommel; R Tsang; Giancarlo Pruneri; Kally Yuen; D Roos; A Lennard; liliana devizzi; S Crabb; D Hossfeld; G Pratt; M Dell'Olio; S P Choo; R G Bociek; J Radford; S Lade; ALESSANDRO MASSIMO GIANNI; Emanuele Zucca; Franco Cavalli; John F Seymour
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):233-41.
2008: Carmelo Carlo-Stella; Cristiana Lavazza; Antonino Carbone; ALESSANDRO MASSIMO GIANNI
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.
Advances in experimental medicine and biology 2008;610():100-11.
2007: Christian Gisselbrecht; W Bethge; R F Duarte; ALESSANDRO MASSIMO GIANNI; Bertram Glaß; Corinne Haioun; G Martinelli; A Nagler; R Pettengell; A Sureda; Hervé Tilly; K Wilson
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 2007;40(11):1007-17.
2007: Paolo Corradini; Anna Dodero; Lucia Farina; Renato Fanin; Francesca Patriarca; Rosalba Miceli; Paola Matteucci; Marco Bregni; Rosanna Scimè; Franco Narni; Enrico Pogliani; Anna Locasciulli; Raffaella Milani; C Carniti; Andrea Bacigalupo; Alessandro Rambaldi; Francesca Bonifazi; Attilio Olivieri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.
Leukemia 2007;21(11):2316-23.
2007: Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Roberta Calvi; Alessandra Pescarollo; Valerio Zoli; A Fornari; Domenico Novero; Antonello Cabras; M Stella; A Comino; Daniele Remotti; Maurilio Ponzoni; Daniele Caracciolo; marco ladetto; Michele Magni; liliana devizzi; Rosalba Rosato; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvatore Mirto; ALESSANDRO MASSIMO GIANNI
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Leukemia 2007;21(8):1802-11.
2007: Cristiana Lavazza; Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Marco Milanesi; Michele Magni; ALESSANDRO MASSIMO GIANNI
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.
Experimental hematology 2007;35(6):888-97.
2007: Carmelo Carlo-Stella; Cristiana Lavazza; Alberta Locatelli; Lucia Viganò; ALESSANDRO MASSIMO GIANNI; Luca Gianni
Targeting TRAIL agonistic receptors for cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2313-7.
2007: Carmelo Carlo-Stella; Anna Guidetti; Massimo Di Nicola; Cristiana Lavazza; Loredana Cleris; Daniela Sia; Paolo Longoni; Marco Milanesi; Michele Magni; Zoltan Nagy; Paolo Corradini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
Cancer research 2007;67(7):3269-75.
2007: Susan P Perrine; Olivier Hermine; Trudy N Small; Felipe Suarez; Richard J O'Reilly; Farid Boulad; Joyce Diane Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Christoph Klein; Steven Horwitz; Douglas V Faller
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Blood 2007;109(6):2571-8.
2007: Carlo Chiesa; Francesca Botta; Erika Di Betta; Angela Coliva; Marco Maccauro; Gianluca Aliberti; Sergio Bavusi; liliana devizzi; Anna Guidetti; Ettore Seregni; ALESSANDRO MASSIMO GIANNI; Emilio Bombardieri
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):113-20.
2007: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Loredana Cleris; Cristiana Lavazza; Raffaella Milani; Marco Milanesi; Michele Magni; Virgilio Pace; Francesco Colotta; Maria A Avanzini; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Stem cells (Dayton, Ohio) 2007;25(1):252-61.
2006: marco ladetto; Michele Magni; Gloria Pagliano; Federica De Marco; Daniela Drandi; Irene Ricca; Monica Astolfi; Paola Matteucci; Anna Guidetti; Barbara Mantoan; Chiara Lobetti Bodoni; Manuela Zanni; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1270-6.
2006: Vittorio Perfetti; Salvatore Siena; Giovanni Palladini; Marco Bregni; Massimo Di Nicola; Laura Obici; Michele Magni; Laura Brunetti; ALESSANDRO MASSIMO GIANNI; Giampaolo Merlini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Haematologica 2006;91(12):1635-43.
2006: Carmelo Carlo-Stella; Cristiana Lavazza; Massimo Di Nicola; Loredana Cleris; Paolo Longoni; Marco Milanesi; Michele Magni; Daniele Morelli; Annunziata Gloghini; Antonino Carbone; ALESSANDRO MASSIMO GIANNI
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Human gene therapy 2006;17(12):1225-40.
2006: Carlo Visco; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Valeria Bonfante; Simonetta Viviani; ALESSANDRO MASSIMO GIANNI; Massimo Federico; stefano luminari; Prema P Peethambaram; Thomas E Witzig; Gerassimos A Pangalis; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris; Giovanni Pizzolo
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
European journal of haematology 2006;77(5):387-94.
2006: Paolo Corradini; Corrado Tarella; Francesco Zallio; Anna Dodero; Manuela Zanni; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi; T Barbui; Sergio Cortelazzo
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.
Leukemia 2006;20(9):1533-8.
2006: Carmelo Carlo-Stella; Anna Guidetti; Massimo Di Nicola; Paolo Longoni; Loredana Cleris; Cristiana Lavazza; Marco Milanesi; Raffaella Milani; Matteo Carrabba; Lucia Farina; Franca Formelli; ALESSANDRO MASSIMO GIANNI; Paolo Corradini
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Experimental hematology 2006;34(6):721-7.
2006: Paola Matteucci; Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Anna Guidetti; Maddalena Marchesi; ALESSANDRO MASSIMO GIANNI
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Haematologica 2006;91(2):255-7.
2006: Carmelo Carlo-Stella; Massimo Di Nicola; Maria Caterina Turco; Loredana Cleris; Cristiana Lavazza; Paolo Longoni; Marco Milanesi; Michele Magni; Massimo Ammirante; Arturo Leone; Zoltan Nagy; Walter R Gioffrè; Franca Formelli; ALESSANDRO MASSIMO GIANNI
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Cancer research 2006;66(3):1799-808.
2006: Andrea Anichini; Roberta Mortarini; Luca Romagnoli; Paola Baldassari; Antonello Cabras; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI; Massimo Di Nicola
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.
Blood 2006;107(2):602-9.
2006: Lorena Passoni; Barbara Gallo; Elia Biganzoli; Roberta Stefanoni; maura massimino; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Carlo Gambacorti-Passerini
In vivo T-cell immune response against anaplastic lymphoma kinase in patients with anaplastic large cell lymphomas.
Haematologica 2006;91(1):48-55.
2005: Pier Adelchi Ruffini; Massimo Di Nicola; Carmelo Carlo-Stella; Salvatore Siena; ALESSANDRO MASSIMO GIANNI
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
Current gene therapy 2005;5(5):511-21.
2005: Paolo Corradini; Francesco Zallio; J Mariotti; Lucia Farina; Marco Bregni; Pinuccia Valagussa; Fabio Ciceri; Andrea Bacigalupo; Anna Dodero; Moira Lucesole; Francesca Patriarca; Alessandro Rambaldi; Rosanna Scimè; Anna Locasciulli; Giuseppe Bandini; ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Attilio Olivieri
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6690-8.
2005: Gianni Bonadonna; Simonetta Viviani; Valeria Bonfante; ALESSANDRO MASSIMO GIANNI; Pinuccia Valagussa
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2005: Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
Biology and clinical applications of marrow mesenchymal stem cells.
Pathologie-biologie 2005;53(3):162-4.
2005: Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Bone marrow transplantation for lymphoma CR1.
Current opinion in oncology 2005;17(2):99-105.
2004: Carlo Visco; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; L Jeffrey Medeiros; P Notti; George Z Rassidakis; Prema P Peethambaram; Richard Wilder; Thomas E Witzig; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Jacopo Mariotti; liliana devizzi; maura massimino; Antonello Cabras; Michele Magni; Paola Matteucci; Anna Guidetti; Lorenza Gandola; ALESSANDRO MASSIMO GIANNI
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
British journal of haematology 2004;126(6):815-20.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Roberta Mortarini; Paola Baldassari; Anna Guidetti; Gianfrancesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Michele Magni; Paul Chaplin; Natale Cascinelli; Giorgio Parmiani; ALESSANDRO MASSIMO GIANNI; Andrea Anichini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5381-90.
2004: Paolo Corradini; Anna Dodero; Francesco Zallio; Daniele Caracciolo; Marco Casini; Marco Bregni; Franco Narni; Francesca Patriarca; Mario Boccadoro; Fabio Benedetti; Alessandro Rambaldi; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2172-6.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Raffaella Milani; Anna Guidetti; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Franca Formelli; Fernando Ravagnani; Paolo Corradini; ALESSANDRO MASSIMO GIANNI
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
Blood 2004;103(9):3287-95.
2004: Heather M Bond; Maria Mesuraca; Ennio Carbone; Patrizia Bonelli; Valter Agosti; Nicola Amodio; Gaetano De Rosa; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Malcolm A S Moore; Akiko Hata; Michele Grieco; Giovanni Morrone; Salvatore Venuta
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.
Blood 2004;103(6):2062-70.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Raffaella Milani; Paolo Longoni; Marco Milanesi; Carlo Bifulco; Claudio Stucchi; Anna Guidetti; Loredana Cleris; Franca Formelli; Gianni Garotta; ALESSANDRO MASSIMO GIANNI
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Experimental hematology 2004;32(2):171-8.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Raffaella Milani; Marco Milanesi; Anna Guidetti; Krista G Haanstra; margreet jonker; Loredana Cleris; Michele Magni; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor.
Experimental hematology 2004;32(1):68-75.
2003: Massimo Di Nicola; Sara Napoli; Andrea Anichini; Roberta Mortarini; Luca Romagnoli; Michele Magni; Paola Matteucci; Paola Baldassarri; Ilaria Bersani; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.
Haematologica 2003;88(12):1396-404.
2003: Annarita Conconi; Giovanni Martinelli; Catherine Thiéblemont; Andrés J M Ferreri; liliana devizzi; Fedro Alessandro Peccatori; Maurilio Ponzoni; Ennio Pedrinis; Stefania Dell'Oro; Giancarlo Pruneri; Virginio Filipazzi; Pierre-Yves Dietrich; ALESSANDRO MASSIMO GIANNI; Bertrand Coiffier; Franco Cavalli; Emanuele Zucca
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.
Blood 2003;102(8):2741-5.
2003: Massimo Di Nicola; Carmelo Carlo-Stella; Andrea Anichini; Roberta Mortarini; Anna Guidetti; Gabrina Tragni; Francesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Daniele Morelli; Paul Chaplin; Nathaly Arndtz; Gerd Sutter; Ingo Drexler; Giorgio Parmiani; Natale Cascinelli; ALESSANDRO MASSIMO GIANNI
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Human gene therapy 2003;14(14):1347-60.
2003: Alessandra Cuttica; Francesco Zallio; marco ladetto; Massimo Di Nicola; Daniele Caracciolo; Michele Magni; Carlo Marinone; Maria Dell'Aquila; Michela Rosace; Alessandro Pileri; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Cancer 2003;98(5):983-92.
2003: ALESSANDRO MASSIMO GIANNI; Michele Magni; Maurizio Martelli; Massimo Di Nicola; Carmelo Carlo-Stella; Silvana Pilotti; Alessandro Rambaldi; Sergio Cortelazzo; Caterina Patti; Guido Parvis; Fabio Benedetti; Saveria Capria; Paolo Corradini; Corrado Tarella; Tiziano Barbui
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).
Blood 2003;102(2):749-55.
2003: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di Nicola; Sergio Cortelazzo; Rosalba Rosato; Carlo Rosanelli; Nicola Di Renzo; Maurizio Musso; Enzo Pavone; Gino Santini; Alessandra Pescarollo; Alberto De Crescenzo; Massimo Federico; Andrea Gallamini; Patrizia Pregno; Roberta Romano; Paolo Coser; Eugenio Gallo; Mario Boccadoro; Tiziano Barbui; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Alessandro Levis
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Cancer 2003;97(11):2748-59.
2003: Emanuele Zucca; Annarita Conconi; T I Mughal; A H Sarris; J F Seymour; Umberto Vitolo; R Klasa; M Ozsahin; G M Mead; ALESSANDRO MASSIMO GIANNI; Sergio Cortelazzo; Andrés J M Ferreri; Achille Ambrosetti; M Martelli; C Thiéblemont; H Gomez Moreno; Graziella Pinotti; G Martinelli; Ruggero Mozzana; S Grisanti; Mariano Provencio; Monica Balzarotti; F Laveder; G Oltean; Vincenzo Callea; P Roy; Franco Cavalli; Mary K Gospodarowicz
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):20-7.
2002: Pier Luigi Zinzani; Maurizio Martelli; Marilena Bertini; ALESSANDRO MASSIMO GIANNI; liliana devizzi; Massimo Federico; Gerassimos Pangalis; Jorg Michels; Emanuele Zucca; Maria Cantonetti; Sergio Cortelazzo; Andrew Wotherspoon; Andrés J M Ferreri; Francesco Zaja; Francesco Lauria; Amalia De Renzo; Marina A Liberati; Brunangelo Falini; Monica Balzarotti; Antonello Calderoni; Alfonso Zaccaria; Patrizia Gentilini; Pier Paolo Fattori; Enzo Pavone; Maria K Angelopoulou; Lapo Alinari; Maura Brugiatelli; Nicola Di Renzo; Francesca Bonifazi; Stefano A Pileri; Franco Cavalli
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
Haematologica 2002;87(12):1258-64.
2002: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; Cristiana Lavazza; Salvatore Grisanti; Carlo Bifulco; Silvana Pilotti; Daniela Papini; Juan Rosai; ALESSANDRO MASSIMO GIANNI
Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.
Leukemia research 2002;26(12):1131-3.
2002: Corrado Tarella; Massimo Di Nicola; Daniele Caracciolo; Francesco Zallio; Alessandra Cuttica; Paola Omedè; P Bondesan; Michele Magni; Paola Matteucci; Andrea Gallamini; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Bone marrow transplantation 2002;30(11):725-32.
2002: George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Timothy J McDonnell; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: ALESSANDRO MASSIMO GIANNI; Neil L Berinstein; Paul A S Evans; Armando López-Guillermo; Carlos Solano
Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcome.
Anti-cancer drugs 2002;13 Suppl 2():S35-42.
2002: Carmelo Carlo-Stella; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI
[Mesenchymal stem cells: biology and clinical applications].
Tumori 2002;88(6):A4-7.
2002: Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Claudio Stucchi; Loredana Cleris; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
Cancer research 2002;62(21):6152-7.
2002: Paola Matteucci; Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Caterina Uberti; ALESSANDRO MASSIMO GIANNI
Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody.
Blood 2002;100(3):1104-5.
2002: Sergio Cortelazzo; Andrea Rossi; Elena Oldani; Teresio Motta; Roberto Giardini; Pier Luigi Zinzani; Emanuele Zucca; Henry Gomez; Andrés J M Ferreri; Graziella Pinotti; Claudio Chini; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Franco Cavalli; Tiziano Barbui
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies.
British journal of haematology 2002;118(1):218-28.
2002: Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Salvatore Grisanti; ALESSANDRO MASSIMO GIANNI
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood 2002;99(10):3838-43.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: ALESSANDRO MASSIMO GIANNI; Sergio Cortelazzo; Michele Magni; M Martelli
Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.
Bone marrow transplantation 2002;29 Suppl 1():S10-3.
2002: George Z Rassidakis; L Jeffrey Medeiros; Timothy J McDonnell; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Paolo Corradini; Corrado Tarella; Attilio Olivieri; ALESSANDRO MASSIMO GIANNI; Claudia Voena; Francesco Zallio; marco ladetto; Michele Falda; Moira Lucesole; Anna Dodero; Fabio Ciceri; Fabio Benedetti; Alessandro Rambaldi; Maria R Sajeva; Moreno Tresoldi; Alessandro Pileri; Claudio Bordignon; Marco Bregni
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Blood 2002;99(1):75-82.
2001: Paolo Corradini; Claudia Voena; Monica Astolfi; S Delloro; S Pilotti; G Arrigoni; Marco Bregni; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(12):1693-8.
2001: marco ladetto; Francesco Zallio; Sonia Vallet; Irene Ricca; Alessandra Cuttica; Daniele Caracciolo; Paolo Corradini; Monica Astolfi; Selina Sametti; Federica Volpato; P Bondesan; Umberto Vitolo; Mario Boccadoro; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.
Leukemia 2001;15(12):1941-9.
2001: Marco Herling; George Z Rassidakis; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; ALESSANDRO MASSIMO GIANNI; SW Morris; Fernando Cabanillas; L Jeffrey Medeiros; Andreas H Sarris
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
Leukemia & lymphoma 2001;42(5):969-79.
2001: Sergio Cortelazzo; Alessandro Rambaldi; Andrea Rossi; Elena Oldani; M Ghielmini; F Benedetti; Corrado Tarella; F Zaglio; Umberto Vitolo; Massimo Di Nicola; Enrico Pogliani; Franco Cavalli; ALESSANDRO MASSIMO GIANNI; Tiziano Barbui
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
British journal of haematology 2001;114(2):333-41.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2001: Corrado Tarella; Francesco Zallio; Daniele Caracciolo; Alessandra Cuttica; Paolo Corradini; Paolo Gavarotti; marco ladetto; V Podio; A Sargiotto; G Rossi; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity.
Leukemia 2001;15(2):256-63.
2000: Massimo Di Nicola; Carmelo Carlo-Stella; Marco Milanesi; Michele Magni; Paolo Longoni; Roberta Mortarini; Andrea Anichini; Rosella Tomanin; MAURIZIO SCARPA; ALESSANDRO MASSIMO GIANNI
Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex.
British journal of haematology 2000;111(1):344-50.
2000: Michele Magni; Massimo Di Nicola; liliana devizzi; Paola Matteucci; F Lombardi; Lorenza Gandola; Fernando Ravagnani; Roberto Giardini; G Dastoli; Corrado Tarella; Alessandro Pileri; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
2000: ALESSANDRO MASSIMO GIANNI; M J Piccart
Optimising chemotherapy dose density and dose intensity. new strategies to improve outcomes in adjuvant therapy for breast cancer.
European journal of cancer (Oxford, England : 1990) 2000;36 Suppl 1():S1-3.
1999: Mario Boccadoro; Corrado Tarella; Antonio Palumbo; C Argentino; S Triolo; Alida Dominietto; Vincenzo Callea; Vito Michele Lauta; Stefano Molica; Pellegrino Musto; Filippo Marmont; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
Haematologica 1999;84(10):905-10.
1999: Andrea Anichini; Alessandra Molla; Roberta Mortarini; Gabrina Tragni; Ilaria Bersani; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Silvana Pilotti; R Dunbar; V Cerundolo; Giorgio Parmiani
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
The Journal of experimental medicine 1999;190(5):651-67.
1999: Massimo Di Nicola; Marco Milanesi; Michele Magni; Marco Bregni; Carmelo Carlo-Stella; Paolo Longoni; Rosella Tomanin; Fernando Ravagnani; MAURIZIO SCARPA; Craig T Jordan; ALESSANDRO MASSIMO GIANNI
Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes.
Human gene therapy 1999;10(11):1875-84.
1999: Salvatore Siena; Marco Bregni; ALESSANDRO MASSIMO GIANNI
Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):27-39.
1999: Vittorio Perfetti; P Ubbiali; Michele Magni; M Colli Vignarelli; Simona Casarini; Paola Matteucci; ALESSANDRO MASSIMO GIANNI; Giampaolo Merlini
Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis.
Bone marrow transplantation 1999;23(4):323-7.
1999: Massimo Di Nicola; Paolo Longoni; Michele Magni; ALESSANDRO MASSIMO GIANNI
The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34+ progenitor cells: the importance of the source of serum.
Experimental hematology 1999;27(2):386-7.
1999: Fernando Ravagnani; Salvatore Siena; S De Reys; Massimo Di Nicola; Paola Notti; Roberto Giardini; Marco Bregni; Paola Matteucci; ALESSANDRO MASSIMO GIANNI; G Pellegris
Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system.
Transfusion 1999;39(1):48-55.
1998: Massimo Di Nicola; Andrea Anichini; Roberta Mortarini; Marco Bregni; G Parmiani; ALESSANDRO MASSIMO GIANNI
Human dendritic cells: natural adjuvants in antitumor immunotherapy.
Cytokines, cellular & molecular therapy 1998;4(4):265-73.
1998: Elda Tagliabue; S Pilotti; ALESSANDRO MASSIMO GIANNI; S Ménard; M I Colnaghi
Target molecules for immunotherapy of inflammatory breast carcinomas.
European journal of cancer (Oxford, England : 1990) 1998;34(12):1982-3.
1998: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Paolo Longoni; Michele Magni; Marco Milanesi; Paola Matteucci; Roberta Mortarini; Andrea Anichini; Giorgio Parmiani; Ingo Drexler; Volker Erfle; Gerd Sutter; ALESSANDRO MASSIMO GIANNI
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
Cancer gene therapy 1998;5(6):350-6.
1998: Arturo Chiti; Massimo Di Nicola; A Spinelli; Salvatore Siena; Marco Bregni; Giordano Savelli; ALESSANDRO MASSIMO GIANNI; Emilio Bombardieri
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: clinical usefulness of [99mTc]- sestamibi.
Tumori 1998;84(5):612-3.
1998: Guido Cavaletti; G Bogliun; A Zincone; L Marzorati; Paola Melzi; Lodovico Frattola; M Marzola; Cristina Bonazzi; Maria Grazia Cantù; Stefania Chiari; A Galli; Marco Bregni; ALESSANDRO MASSIMO GIANNI
Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients.
Anticancer research 1998;18(5B):3797-802.
1998: Marco Bregni; S Shammah; F Malaffo; Massimo Di Nicola; Marco Milanesi; Michele Magni; Paola Matteucci; Fernando Ravagnani; Craig T Jordan; Salvatore Siena; ALESSANDRO MASSIMO GIANNI
Adenovirus vectors for gene transduction into mobilized blood CD34+ cells.
Gene therapy 1998;5(4):465-72.
1998: Marco Bregni; Massimo Di Nicola; Salvatore Siena; N Belli; Marco Milanesi; S Shammah; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells.
Haematologica 1998;83(3):204-8.
1997: Roberta Mortarini; Andrea Anichini; Massimo Di Nicola; Salvatore Siena; Marco Bregni; F Belli; Alessandra Molla; ALESSANDRO MASSIMO GIANNI; G Parmiani
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
Cancer research 1997;57(24):5534-41.
1997: ALESSANDRO MASSIMO GIANNI
High-dose chemotherapy and autotransplants: a time for guidelines.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):933-5.
1997: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; M Di Nicola; S Orefice; F Cusumano; Bruno Salvadori; Alberto Luini; Marco Greco; Roberto Zucali; F Rilke; Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2312-21.
1997: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; C Brambilla; Massimo Di Nicola; F Lombardi; Lorenza Gandola; Corrado Tarella; Alessandro Pileri; Fernando Ravagnani; Pinuccia Valagussa; Gianni Bonadonna
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1996: Massimo Di Nicola; Salvatore Siena; Paolo Corradini; Marco Bregni; Marco Milanesi; Michele Magni; P A Ruffini; Fernando Ravagnani; Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Bone marrow transplantation 1996;18(6):1117-21.
1996: Massimo Di Nicola; Salvatore Siena; Marco Bregni; N Belli; Marco Milanesi; P A Ruffini; F Malaffo; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substitute.
Bone marrow transplantation 1996;18(3):619-23.
1996: Massimo Di Nicola; Marco Bregni; Salvatore Siena; P A Ruffini; Marco Milanesi; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Combined negative and positive selection of mobilized CD34 blood cells.
British journal of haematology 1996;94(4):716-21.
1996: Pierfrancesco Tassone; Maria Caterina Turco; Franca Tuccillo; Patrizia Bonelli; Giovanni Morrone; L Cecco; M Cerra; Heather M Bond; M Di Nicola; ALESSANDRO MASSIMO GIANNI; Salvatore Venuta
CD69 expression on primitive progenitor cells and hematopoietic malignancies.
Tissue antigens 1996;48(1):65-8.
1996: Salvatore Siena; Marco Bregni; Massimo Di Nicola; Michele Magni; Fernando Ravagnani; L Gandola; F Lombardi; ALESSANDRO MASSIMO GIANNI
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation].
Tumori 1996;82(2 Suppl):S23-7.
1996: ALESSANDRO MASSIMO GIANNI
[The use of peripheral blood progenitor cells (PBPC) in oncology. Introduction].
Tumori 1996;82(2 Suppl):S1-2.
1996: Marco Bregni; Salvatore Siena; Massimo Di Nicola; A Dodero; Fedro Alessandro Peccatori; Fernando Ravagnani; G Danesini; A Laffranchi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):628-35.
1996: Graça Almeida-Porada; R Hoffman; P Manalo; ALESSANDRO MASSIMO GIANNI; Esmail D Zanjani
Detection of human cells in human/sheep chimeric lambs with in vitro human stroma-forming potential.
Experimental hematology 1996;24(3):482-7.
1996: Michele Magni; S Shammah; R Schiró; W Mellado; Riccardo Dalla-Favera; ALESSANDRO MASSIMO GIANNI
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.
Blood 1996;87(3):1097-103.
1996: Edward F Srour; M Bregni; CM Traycoff; B Agüero; S T Kosak; R Hoffman; S Siena; ALESSANDRO MASSIMO GIANNI
Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Blood cells, molecules & diseases 1996;22(1):68-81.
1995: Salvatore Siena; Massimo Di Nicola; Marco Bregni; Roberta Mortarini; Andrea Anichini; L Lombardi; Fernando Ravagnani; G Parmiani; ALESSANDRO MASSIMO GIANNI
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
Experimental hematology 1995;23(14):1463-71.
1995: Corrado Tarella; G Benedetti; Daniele Caracciolo; Claudia Castellino; C Cherasco; P Bondesan; P Omedé; D Ruggieri; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF.
British journal of haematology 1995;91(3):535-43.
1995: Luca Gianni; V Bellotti; ALESSANDRO MASSIMO GIANNI; G Merlini
New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin.
Blood 1995;86(3):855-61.
1995: Corrado Tarella; Daniele Caracciolo; Paolo Gavarotti; P Bondesan; C Cherasco; Paola Omedè; Marco Bregni; Salvatore Siena; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization.
Bone marrow transplantation 1995;16(2):223-8.
1995: C C Stella; M Cazzola; Paolo De Fabritiis; A de Vincentiis; ALESSANDRO MASSIMO GIANNI; F Lanza; F Lauria; Roberto M Lemoli; Corrado Tarella; P Zanon
CD34-positive cells: biology and clinical relevance.
Haematologica 1995;80(4):367-87.
1995: M Boogaerts; F Cavalli; H Cortés-Funes; J M Gatell; ALESSANDRO MASSIMO GIANNI; D Khayat; Y Levy; H Link
Granulocyte growth factors: achieving a consensus.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):237-44.
1994: Salvatore Siena; Marco Bregni; Massimo Di Nicola; F Ravagani; Fedro Alessandro Peccatori; L Gandola; F Lombardi; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):935-41.
1994: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fernando Ravagnani; F Vitello; N Belli; A Dodero; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Bone marrow transplantation 1994;14(6):863-9.
1994: CA Juttner; W E Fibbe; J Nemunaitis; L Kanz; ALESSANDRO MASSIMO GIANNI
Blood cell transplantation: report from an International Consensus Meeting.
Bone marrow transplantation 1994;14(5):689-93.
1994: ALESSANDRO MASSIMO GIANNI
Where do we stand with respect to the use of peripheral blood progenitor cells?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):781-4.
1994: J Tong; R Hoffman; S Siena; Edward F Srour; M Bregni; ALESSANDRO MASSIMO GIANNI
Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
Experimental hematology 1994;22(10):1016-24.
1994: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Marco Bregni; Salvatore Siena; F Lombardi; L Gandola; Daniele Caracciolo; A Stern; Gianni Bonadonna; Mario Boccadoro
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):503-9.
1994: G Benedetti; P Bondesan; Daniele Caracciolo; C Cherasco; D Ruggieri; M E Gastaldi; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Experimental hematology 1994;22(2):166-73.
1994: Bruno Brando; S Siena; M Bregni; ALESSANDRO MASSIMO GIANNI; P Grillo; E Sommaruga
A standardized flow cytometry protocol for mobilized peripheral CD34+ cells estimation and collection for autotransplantation in cancer patients.
European journal of histochemistry : EJH 1994;38 Suppl 1():21-6.
1994: J Tong; ALESSANDRO MASSIMO GIANNI; S Siena; Edward F Srour; M Bregni; R Hoffman
Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
Blood cells 1994;20(2-3):351-62; discussion 362-3.
1994: M Bregni; S Siena; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).
European journal of cancer (Oxford, England : 1990) 1994;30A(2):235-8.
1993: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; L Zorzino; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
The International journal of artificial organs 1993;16 Suppl 5():80-2.
1993: Fernando Ravagnani; Paola Notti; Salvatore Siena; Marco Bregni; L Zorzino; Massimo Di Nicola; N Belli; ALESSANDRO MASSIMO GIANNI; G Pellegris
Clinical application of growth factors for collection of circulating hematopoietic progenitors in breast cancer patients treated with high-dose cyclophosphamide.
The International journal of artificial organs 1993;16 Suppl 5():35-8.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Massimo Di Nicola; Michele Magni; Fedro Alessandro Peccatori; P Valagussa; Gianni Bonadonna
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):889-91.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; Massimo Di Nicola; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; I Sklenar; Gianni Bonadonna
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):759-66.
1993: Salvatore Siena; Marco Bregni; Laura Bonsi; I Sklenar; Gian Paolo Bagnara; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Experimental hematology 1993;21(12):1583-90.
1993: Elena M Faioni; A Krachmalnicoff; S I Bearman; Augusto B Federici; Adriano Decarli; ALESSANDRO MASSIMO GIANNI; G B McDonald; Pier M Mannucci
Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver.
Blood 1993;81(12):3458-62.
1993: Corrado Tarella; Mario Boccadoro; P Omedé; P Bondesan; Daniele Caracciolo; R Frieri; Marco Bregni; Salvatore Siena; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
Bone marrow transplantation 1993;11(4):271-7.
1993: S Siena; M Bregni; ALESSANDRO MASSIMO GIANNI
Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
Experimental hematology 1993;21(2):203-5.
1992: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; Michele Magni; Massimo Di Nicola; F Lombardi; Corrado Tarella; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: ALESSANDRO MASSIMO GIANNI; S Siena; M Bregni; Gianni Bonadonna
The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy.
Pathologie-biologie 1992;39(9):956.
1992: Marco Bregni; Michele Magni; Salvatore Siena; Massimo Di Nicola; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.
Blood 1992;80(6):1418-22.
1992: A Orazi; G Cattoretti; R Schiró; S Siena; M Bregni; M Di Nicola; ALESSANDRO MASSIMO GIANNI
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
Blood 1992;79(10):2610-9.
1992: K Antman; R Corringham; E de Vries; Gerald J Elfenbein; ALESSANDRO MASSIMO GIANNI; C Gisselbrecht; R Herzig; C Juttner; H Kaizer; M J Kennedy
Dose intensive therapy in breast cancer.
Bone marrow transplantation 1992;10 Suppl 1():67-73.
1991: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Pinuccia Valagussa; Gianni Bonadonna
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):645-53.
1991: Salvatore Siena; Marco Bregni; B Brando; N Belli; P M Lansdorp; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.
Haematologica 1991;76(4):330-3.
1991: ALESSANDRO MASSIMO GIANNI; M Bregni; S Siena; C Tarella; M DiNicola; G Bonadonna
[Clinical use of hematopoietic growth factors].
Haematologica 1991;76 Suppl 3():3-10.
1991: Fernando Ravagnani; Salvatore Siena; Marco Bregni; B Brando; N Belli; P M Lansdorp; Paola Notti; G Pellegris; ALESSANDRO MASSIMO GIANNI
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Haematologica 1991;76 Suppl 1():46-9.
1991: ALESSANDRO MASSIMO GIANNI; S Siena; M Bregni
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.
Experimental hematology 1991;19(2):147-8.
1991: Salvatore Siena; Marco Bregni; B Brando; N Belli; Fernando Ravagnani; L Gandola; A C Stern; P M Lansdorp; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Blood 1991;77(2):400-9.
1991: M Bregni; S Siena; M Di Nicola; G Bonadonna; ALESSANDRO MASSIMO GIANNI
Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy.
European journal of cancer (Oxford, England : 1990) 1991;27(5):561-5.
1991: Corrado Tarella; Dario Ferrero; Marco Bregni; Salvatore Siena; E Gallo; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF.
European journal of cancer (Oxford, England : 1990) 1991;27(1):22-7.
1991: Marco Bregni; Salvatore Siena; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Leukemia 1991;5 Suppl 1():123-7.
1991: Gianni Bonadonna; Armando Santoro; ALESSANDRO MASSIMO GIANNI; Simonetta Viviani; Salvatore Siena; Marco Bregni; Roberto Zucali; F Lombardi; Valeria Bonfante; Luca Gianni
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():9-16.
1990: Lorenza Gandola; S Siena; M Bregni; E Sverzellati; P Piotti; C Stucchi; ALESSANDRO MASSIMO GIANNI; F Lombardi
Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
International journal of radiation oncology, biology, physics 1990;19(3):743-9.
1990: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Salvatore Siena; Marco Bregni; Mario Boccadoro; F Lombardi; C Bengala; Gianni Bonadonna; A Pileri
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.
Bone marrow transplantation 1990;6(2):143-5.
1990: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; A Orazi; A C Stern; L Gandola; Gianni Bonadonna
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):768-78.
1990: Corrado Tarella; Dario Ferrero; Salvatore Siena; E Gallo; P Bondesan; Marco Bregni; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment.
Haematologica 1990;75 Suppl 1():11-4.
1990: Lorenza Gandola; F Lombardi; S Siena; M Bregni; P Piotti; E Sverzellati; C Stucchi; G Bonadonna; ALESSANDRO MASSIMO GIANNI; A Lattuada
Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, Italy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18 Suppl 1():105-9.
1990: Marco Bregni; Salvatore Siena; Fernando Ravagnani; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
Haematologica 1990;75 Suppl 1():95-8.
1990: Salvatore Siena; Marco Bregni; Fernando Ravagnani; B Brando; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
Haematologica 1990;75 Suppl 1():6-10.
1990: Fernando Ravagnani; Marco Bregni; Salvatore Siena; Gianalfredo Sciorelli; ALESSANDRO MASSIMO GIANNI; G Pellegris
Role of recombinant human granulocyte-macrophage colony stimulating factor for large scale collection of peripheral blood stem cells for autologous transplantation.
Haematologica 1990;75 Suppl 1():22-5.
1990: Fernando Ravagnani; Salvatore Siena; Marco Bregni; Gianalfredo Sciorelli; ALESSANDRO MASSIMO GIANNI; G Pellegris
Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF.
European journal of cancer (Oxford, England : 1990) 1990;26(5):562-4.
1990: Alessandro Pileri; Corrado Tarella; Marco Bregni; Mario Boccadoro; Salvatore Siena; Daniele Caracciolo; G Bonadonna; ALESSANDRO MASSIMO GIANNI
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma.
Haematologica 1990;75 Suppl 1():79-82.
1989: Salvatore Siena; Marco Bregni; B Brando; Fernando Ravagnani; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1989;74(6):1905-14.
1989: ALESSANDRO MASSIMO GIANNI; M Bregni; S Siena; C Tarella
[Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
Haematologica 1989;74(5 Suppl):511-26.
1989: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; C Tarella; A C Stern; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation.
Lancet 1989;2(8663):580-5.
1989: ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna
High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?
European journal of cancer & clinical oncology 1989;25(7):1027-30.
1989: M Bregni; M G Borrello; S Siena; A Orazi; D Biassoni; G Bonadonna; ALESSANDRO MASSIMO GIANNI
Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis.
Haematologica 1989;74(4):397-400.
1989: Salvatore Siena; Marco Bregni; A Formosa; B Brando; P Marenco; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
Cancer research 1989;49(12):3328-32.
1989: F Marcucci; D A Lappi; M Ghislieri; D Martineau; A Formosa; Salvatore Siena; Marco Bregni; Marco Soria; ALESSANDRO MASSIMO GIANNI
In vivo effects in mice of an anti-T cell immunotoxin.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(8):2955-60.
1989: Salvatore Siena; Marco Bregni; A Formosa; B Brando; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
Journal of biological regulators and homeostatic agents 1989;3(2):84-8.
1989: Marco Bregni; Salvatore Siena; A Neri; R Bassan; T Barbui; D Delia; Gianni Bonadonna; R Dalla Favera; ALESSANDRO MASSIMO GIANNI
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):338-43.
1989: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; S Villa; Gianalfredo Sciorelli; Fernando Ravagnani; G Pellegris; Gianni Bonadonna
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?
Hematological oncology 1989;7(2):139-48.
1989: Marco Bregni; Salvatore Siena; A Formosa; D A Lappi; D Martineau; F Malavasi; B Dorken; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
Blood 1989;73(3):753-62.
1989: M Bregni; S Siena; M Subar; S Villa; G Bonadonna; R Dalla-Favera; ALESSANDRO MASSIMO GIANNI
Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assay.
Haematologica 1989;74(1):11-4.
1988: Salvatore Siena; Marco Bregni; A Formosa; D Martineau; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation.
Transplantation 1988;46(5):747-53.
1988: Salvatore Siena; D A Lappi; Marco Bregni; A Formosa; S Villa; Marco Soria; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
Blood 1988;72(2):756-65.
1988: Marco Bregni; D A Lappi; Salvatore Siena; A Formosa; S Villa; Marco Soria; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.
Journal of the National Cancer Institute 1988;80(7):511-7.
1987: S Siena; S Villa; G Bonadonna; M Bregni; ALESSANDRO MASSIMO GIANNI
Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Transplantation 1987;43(3):421-6.
1987: Salvatore Siena; S Villa; Gianni Bonadonna; Marco Bregni; ALESSANDRO MASSIMO GIANNI
Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Transplantation proceedings 1987;19(1 Pt 3):2735-7.
1987: Marco Bregni; Salvatore Siena; R Dalla-Favera; ALESSANDRO MASSIMO GIANNI
High sensitivity and specificity assay for detection of leukemia/lymphoma cells in human bone marrow.
Annals of the New York Academy of Sciences 1987;511():473-82.
1987: S Siena; S Villa; M Bregni; G Bonnadonna; ALESSANDRO MASSIMO GIANNI
Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Blood 1987;69(1):345-8.
1984: Cesare Peschle; A R Migliaccio; G Migliaccio; M Petrini; M Calandrini; G Russo; G Mastroberardino; M Presta; ALESSANDRO MASSIMO GIANNI; Paola Comi
Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liver.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(8):2416-20.
1983: M Presta; B Giglioni; S Ottolenghi; ALESSANDRO MASSIMO GIANNI; A Capaldi; M Trento; Giuseppe Saglio
Analysis of human embryonic hemoglobins and globins by isoelectric focusing.
Haematologica 1983;68(4):443-53.
1983: Roberto Taramelli; B Giglioni; Paola Comi; Sergio Ottolenghi; Carlo Brancati; Antonio Tagarelli; E Polli; ALESSANDRO MASSIMO GIANNI
Delta thalassemia: a non-deletion defect.
European journal of biochemistry / FEBS 1983;129(3):589-92.
1983: Cesare Peschle; A R Migliaccio; G Migliaccio; G Russo; G Mastroberardino; Sergio Ottolenghi; B Giglioni; Paola Comi; ALESSANDRO MASSIMO GIANNI; M Presta
Cellular and molecular mechanisms of the human embryonic leads to fetal hemoglobin switch.
Progress in clinical and biological research 1983;134():411-9.
1983: ALESSANDRO MASSIMO GIANNI; M Bregni; M D Cappellini; G Fiorelli; Roberto Taramelli; B Giglioni; Paola Comi; Sergio Ottolenghi
A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster.
The EMBO journal 1983;2(6):921-5.
1982: Sergio Ottolenghi; B Giglioni; Roberto Taramelli; Paola Comi; U Mazza; G Saglio; C Camaschella; Paola Izzo; A Cao; R Galanello; E Gimferrer; M Baiget; ALESSANDRO MASSIMO GIANNI
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area?
Proceedings of the National Academy of Sciences of the United States of America 1982;79(7):2347-51.
1982: ALESSANDRO MASSIMO GIANNI; M Presta; E Polli; Cesare Peschle; F Lettieri; G Saglio; Paola Comi; B Giglioni; Sergio Ottolenghi
Preferential induction of fetal versus embryonic globin chains in human leukemic cell lines.
Leukemia research 1982;6(2):155-63.
1982: Sergio Ottolenghi; B Giglioni; Roberto Taramelli; Paola Comi; ALESSANDRO MASSIMO GIANNI
delta beta-Thalassemia and HPFH.
Birth defects original article series 1982;18(7):65-7.
1982: Cesare Peschle; A R Migliaccio; G Migliaccio; G Mastroberardino; ALESSANDRO MASSIMO GIANNI; Paola Comi; Sergio Ottolenghi; B Giglioni
In vitro regulation of Hb synthesis: studies in normal subjects and thalassemic patients.
Birth defects original article series 1982;18(7):131-8.
1981: Paola Comi; B Giglioni; M L Pozzoli; Sergio Ottolenghi; ALESSANDRO MASSIMO GIANNI; A R Migliaccio; G Migliaccio; F Lettieri; Cesare Peschle
Biosynthesis of globin chains in fetal liver and adult marrow cultures.
Experimental cell research 1981;133(2):347-56.
1981: Sergio Ottolenghi; Roberto Taramelli; B Giglioni; Paola Comi; ALESSANDRO MASSIMO GIANNI
[Prenatal diagnosis of hemoglobinopathies on the DNA of amniotic fluid fibroblasts].
Minerva medica 1981;72(10):647-50.
1981: ALESSANDRO MASSIMO GIANNI; E Polli; B Giglioni; Paola Comi; Sergio Ottolenghi; M Ferrari; M Furbetta; A Angius; Antonio Cao
Isoelectric focusing of globin chains for antenatal diagnosis of beta 0-thalassemia.
Hemoglobin 1981;5(4):349-56.
1980: B Giglioni; Paola Comi; Roberto Taramelli; Sergio Ottolenghi; M A Ciocca-Vasino; C Anè; M D Cappellini; ALESSANDRO MASSIMO GIANNI
Organization of alpha-globin genes in Hb Hasharon (alpha 47 asp replaced by his) carriers.
Blood 1980;56(6):1145-9.
1980: ALESSANDRO MASSIMO GIANNI; Paola Comi; B Giglioni; Sergio Ottolenghi; A R Migliaccio; G Migliaccio; F Lettieri; Y P Maguire; Cesare Peschle
Biosynthesis of Hb in individual fetal liver bursts. gamma-Chain production peaks earlier than beta-chain in the erythropoietic pathway.
Experimental cell research 1980;130(2):345-52.
1980: Cesare Peschle; G Migliaccio; A Covelli; F Lettieri; A R Migliaccio; M Condorelli; Paola Comi; M L Pozzoli; B Giglioni; Sergio Ottolenghi; M D Cappellini; E Polli; ALESSANDRO MASSIMO GIANNI
Hemoglobin synthesis in individual bursts from normal adult blood: all bursts and subcolonies synthesize G gamma-and A gamma-globin chains.
Blood 1980;56(2):218-26.
1980: Cesare Peschle; G Migliaccio; A R Migliaccio; F Lettieri; G Russo; ALESSANDRO MASSIMO GIANNI; Sergio Ottolenghi; Paola Comi; B Giglioni
Erythropoietic differentiation in humans: in vitro studies on erythroid progenitors and Hb synthesis in fetal, newborn and adult life.
Experimental hematology 1980;8 Suppl 8():153-9.
1980: ALESSANDRO MASSIMO GIANNI; R Dalla-Favera; E Polli
Restriction enzyme analysis of human leukemic mitochondrial DNA.
Leukemia research 1980;4(1):155-60.
1980: Paola Comi; B Giglioni; Sergio Ottolenghi; ALESSANDRO MASSIMO GIANNI; E Polli; P Barba; A Covelli; G Migliaccio; M Condorelli; Cesare Peschle
Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(1):362-5.
1979: G Saglio; G Ricco; U Mazza; C Camaschella; P G Pich; ALESSANDRO MASSIMO GIANNI; E Gianazza; P G Righetti; B Giglioni; P Comi; M Gusmeroli; S Ottolenghi
Human T gamma globin chain is a variant of A gamma chain (A gamma Sardinia).
Proceedings of the National Academy of Sciences of the United States of America 1979;76(7):3420-4.
1979: S Ottolenghi; B Giglioni; P Comi; ALESSANDRO MASSIMO GIANNI; E Polli; C T Acquaye; J H Oldham; G Masera
Globin gene deletion in HPFH, delta (o) beta (o) thalassaemia and Hb Lepore disease.
Nature 1979;278(5705):654-7.
1979: B Giglioni; P Comi; R Taramelli; M Pozzoli; A Zanollo; S Ottolenghi; ALESSANDRO MASSIMO GIANNI
beta-Like globin RNA sequences in hemoglobin Lepore disease.
European journal of biochemistry / FEBS 1979;95(3):527-31.
1979: P Comi; B Giglioni; S Ottolenghi; ALESSANDRO MASSIMO GIANNI; G Ricco; U Mazza; G Saglio; C Camaschella; P G Pich; E Gianazza; P G Righetti
G gamma and A gamma globin chains separation and quantitation by isoelectric focusing.
Biochemical and biophysical research communications 1979;87(1):1-8.
1979: P G Righetti; E Gianazza; ALESSANDRO MASSIMO GIANNI; P Comi; B Giglioni; S Ottolenghi; C Secchi; L Rossi-Bernardi
Human globin chain separation by isoelectric focusing.
Journal of biochemical and biophysical methods 1979;1(1):45-57.
1978: ALESSANDRO MASSIMO GIANNI; R Dalla Favera; E Polli; I Merisio; B Giglioni; P Comi; S Ottolenghi
Globin RNA sequences in human leukaemic peripheral blood.
Nature 1978;274(5671):610-2.
1978: E Ginelli; ALESSANDRO MASSIMO GIANNI; G Corneo
Homology between cellular repeated nucleotide sequences and a murine leukemia viral genome.
Tumori 1978;64(4):383-8.
1976: ALESSANDRO MASSIMO GIANNI; J R Hutton; David Smotkin; Robert A. Weinberg
Proviral DNA of Moloney leukemia virus: purification and visualization.
Science (New York, N.Y.) 1976;191(4227):569-71.
1975: David Smotkin; ALESSANDRO MASSIMO GIANNI; S Rozenblatt; Robert A. Weinberg
Infectious viral DNA of murine leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(12):4910-3.
1975: ALESSANDRO MASSIMO GIANNI; Robert A. Weinberg
Partially single-stranded form of free Moloney viral DNA.
Nature 1975;255(5510):646-8.
1975: ALESSANDRO MASSIMO GIANNI; David Smotkin; Robert A. Weinberg
Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(2):447-51.
1975: E Ginelli; ALESSANDRO MASSIMO GIANNI; G Corneo; E Polli
Hybridization of mouse leukemia virus c-DNA to mouse repeated DNA sequences.
Acta haematologica 1975;54(4):221-6.
1973: B Giglioni; ALESSANDRO MASSIMO GIANNI; P Comi; S Ottolenghi; D Rungger
Translational control of globin synthesis by haemin in Xenopus oocytes.
Nature: New biology 1973;246(152):99-102.
1973: S Ottolenghi; P Comi; B Giglioni; ALESSANDRO MASSIMO GIANNI; G G Guidotti
Dissociation of single ribosomes as a preliminary step for their participation in protein synthesis.
European journal of biochemistry / FEBS 1973;33(2):227-32.
1973: P Comi; S Ottolenghi; ALESSANDRO MASSIMO GIANNI; B Giglioni; G G Guidotti
Inhibition of protein synthesis by aliphatic aldehydes. Failure of 2,3-dihydroxybutyraldehyde to inhibit chain initiation in reticulocyte lysates.
Biochimie 1973;55(4):507-8.
1972: ALESSANDRO MASSIMO GIANNI; B Giglioni; S Ottolenghi; P Comi; G G Guidotti
Globin -chain synthesis directed by "supernatant" 10S RNA from rabbit reticulocytes.
Nature: New biology 1972;240(101):183-5.
1971: P Comi; S Ottolenghi; ALESSANDRO MASSIMO GIANNI; B Giglioni; G G Guidotti
Entry of derived ribosomal subunits into polyribosomes during protein synthesis in liver cell-free system.
The Italian journal of biochemistry 1971;20(5):143-55.
1971: ALESSANDRO MASSIMO GIANNI; B Giglioni; P Comi; S Ottolenghi; G G Guidotti
Polyribosomal changes during inhibition of protein synthesis.
Biochimie 1971;53(9):1045-6.
1970: A F Borghetti; P Comi; R Franchi; ALESSANDRO MASSIMO GIANNI; B Giglioni; S Ottolenghi; G G Guidotti
Ribosomal subunits from rat liver. Isolation and recombination into active ribosomal particles.
The Italian journal of biochemistry 1970;19(6):397-416.